Arriola, C., Garg, S., Anderson, E. J., Ryan, P. A., George, A., Zansky, S. M., … & Yousey-Hindes, K. (2017). Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clinical Infectious Diseases, 65(8), 1289-1297.

Ferdinands, J. M., Olsho, L. E., Agan, A. A., Bhat, N., Sullivan, R. M., Hall, M., … & Randolph, A. G. (2014). Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010–2012. The Journal of infectious diseases, 210(5), 674-683.

Flannery, B., Reynolds, S. B., Blanton, L., Santibanez, T. A., O’Halloran, A., Lu, P. J., … & Singleton, J. A. (2017). Influenza vaccine effectiveness against pediatric deaths: 2010–2014. Pediatrics, 139(5), e20164244.

Godoy, P., Romero, A., Soldevila, N., Torner, N., Jané, M., Martínez, A., … & Domínguez, A. (2018). Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16. Eurosurveillance, 23(43).

Grijalva, C. G., Zhu, Y., Williams, D. J., Self, W. H., Ampofo, K., Pavia, A. T., … & Anderson, E. J. (2015). Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. Jama, 314(14), 1488-1497.

Restivo, V., Costantino, C., Bono, S., Maniglia, M., Marchese, V., Ventura, G., … & Vitale, F. (2018). Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies. Human vaccines & immunotherapeutics, 14(3), 724-735.

Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., … & Alden, N. B. (2019). Effects of influenza vaccination in the United States during the 2017–2018 influenza season. Clinical Infectious Diseases, 69(11), 1845-1853.

Thompson, M. G., Pierse, N., Huang, Q. S., Prasad, N., Duque, J., Newbern, E. C., … & McArthur, C. (2018). Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine, 36(39), 5916-5925.

Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., … & Cannon, C. P. (2013). Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. Jama, 310(16), 1711-1720.

Vamos, E. P., Pape, U. J., Curcin, V., Harris, M. J., Valabhji, J., Majeed, A., & Millett, C. (2016). Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ, 188(14), E342-E351.

Walker, E., & Ison, M. G. (2014). Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza and other respiratory viruses, 8(3), 282-292.

Wilkinson, K., Wei, Y., Szwajcer, A., Rabbani, R., Zarychanski, R., Abou-Setta, A. M., & Mahmud, S. M. (2017). Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis. Vaccine, 35(21), 2775-2780.

Wong, K. K., Jain, S., Blanton, L., Dhara, R., Brammer, L., Fry, A. M., & Finelli, L. (2013). Influenza-associated pediatric deaths in the United States, 2004–2012. Pediatrics, 132(5), 796-804.